Revlimid (lenalidomide) - Important Safety Information from Celgene as approved by the Irish Medicines Board
11 February 2011
Important safety information communication from the Irish Medicines Board on the association of Revlimid (lenalidomide) with venous and arterial thromboembolic events.
Important Safety Information communication from Celgene